{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:46:26Z","timestamp":1783597586230,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Mona Taliaferro\/Bay Shore Recycling"},{"DOI":"10.13039\/100000050","name":"The National Heart, Lung and Blood Institute","doi-asserted-by":"crossref","award":["1OT2HL156812-01"],"award-info":[{"award-number":["1OT2HL156812-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FBRI","award":["2022A018462"],"award-info":[{"award-number":["2022A018462"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-33059-7","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T06:26:27Z","timestamp":1766211987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of high-dose long-term therapy of intravenous immunoglobulins in autoimmune autonomic and sensory small fiber neuropathy: a retrospective open-label controlled study"],"prefix":"10.1038","volume":"16","author":[{"given":"Peter","family":"Novak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadie P.","family":"Marciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Felsenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"33059_CR1","doi-asserted-by":"publisher","first-page":"e200286","DOI":"10.1212\/NXI.0000000000200286","volume":"11","author":"AL Oaklander","year":"2024","unstructured":"Oaklander, A. L., Allen, J., Dietliker, N. & Wilder-Smith, E. P. Relapsing-Remitting immunotherapy responsive Small-Fiber neuropathy: longitudinal tracking through 10 years including pregnancies. Neurol. Neuroimmunol. Neuroinflammation. 11, e200286. https:\/\/doi.org\/10.1212\/NXI.0000000000200286 (2024).","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"33059_CR2","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1212\/WNL.0b013e3181a92b52","volume":"72","author":"V Iodice","year":"2009","unstructured":"Iodice, V. et al. Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy. Neurology 72, 2002. https:\/\/doi.org\/10.1212\/WNL.0b013e3181a92b52 (2009).","journal-title":"Neurology"},{"key":"33059_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.autneu.2008.10.022","volume":"146","author":"P Sandroni","year":"2008","unstructured":"Sandroni, P. & Low, P. A. Other autonomic neuropathies associated with ganglionic antibody. Auton. Neurosci. Basic. Clin. 146, 13. https:\/\/doi.org\/10.1016\/j.autneu.2008.10.022 (2008).","journal-title":"Auton. Neurosci. Basic. Clin."},{"key":"33059_CR4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<800::AID-MUS2>3.0.CO;2-F","volume":"22","author":"RH Quarles","year":"1999","unstructured":"Quarles, R. H. & Weiss, M. D. Autoantibodies associated with peripheral neuropathy. Muscle Nerve. 22, 800\u2013822 (1999).","journal-title":"Muscle Nerve"},{"key":"33059_CR5","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1152\/jn.00408.2003","volume":"90","author":"S Vernino","year":"2003","unstructured":"Vernino, S., Low, P. A. & Lennon, V. A. Experimental autoimmune autonomic neuropathy. J. Neurophysiol. 90, 2053\u20132059. https:\/\/doi.org\/10.1152\/jn.00408.2003 (2003).","journal-title":"J. Neurophysiol."},{"key":"33059_CR6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/MJT.0000000000000778","volume":"26","author":"JR Schofield","year":"2019","unstructured":"Schofield, J. R. & Chemali, K. R. Intravenous Immunoglobulin therapy in refractory autoimmune dysautonomias: a retrospective analysis of 38 patients. Am. J. Ther. 26, 570\u2013582. https:\/\/doi.org\/10.1097\/MJT.0000000000000778 (2019).","journal-title":"Am. J. Ther."},{"key":"33059_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/CND.0000000000000485","volume":"25","author":"LA Zeidman","year":"2024","unstructured":"Zeidman, L. A. Effectiveness of IVIG on Non-Length-Dependent skin biopsies in small fiber neuropathy with Plexin D1, trisulfated heparin Disaccharide, and fibroblast growth factor receptor 3 autoantibodies. J. Clin. Neuromuscul. Dis. 25, 184\u2013196. https:\/\/doi.org\/10.1097\/CND.0000000000000485 (2024).","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"33059_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00415-022-11344-z","volume":"270","author":"K Kesterson","year":"2023","unstructured":"Kesterson, K., Schofield, J. & Blitshteyn, S. Immunotherapy with subcutaneous Immunoglobulin or plasmapheresis in patients with postural orthostatic tachycardia syndrome (POTS). J. Neurol. 270, 233\u2013239. https:\/\/doi.org\/10.1007\/s00415-022-11344-z (2023).","journal-title":"J. Neurol."},{"key":"33059_CR9","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1111\/ene.14711","volume":"28","author":"B Rodriguez","year":"2021","unstructured":"Rodriguez, B. et al. Immunomodulatory treatment in postural tachycardia syndrome: a case series. Eur. J. Neurol. 28, 1692\u20131697. https:\/\/doi.org\/10.1111\/ene.14711 (2021).","journal-title":"Eur. J. Neurol."},{"key":"33059_CR10","doi-asserted-by":"publisher","first-page":"e200244","DOI":"10.1212\/NXI.0000000000200244","volume":"11","author":"L McAlpine","year":"2024","unstructured":"McAlpine, L., Zubair, A. S., Joseph, P. & Spudich, S. Case-Control study of individuals with small fiber neuropathy after COVID-19. Neurol. Neuroimmunol. Neuroinflammation. 11, e200244. https:\/\/doi.org\/10.1212\/NXI.0000000000200244 (2024).","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"33059_CR11","doi-asserted-by":"publisher","first-page":"100276","DOI":"10.1016\/j.ensci.2020.100276","volume":"21","author":"P Novak","year":"2020","unstructured":"Novak, P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurologicalSci 21, 100276. https:\/\/doi.org\/10.1016\/j.ensci.2020.100276 (2020).","journal-title":"eNeurologicalSci"},{"key":"33059_CR12","doi-asserted-by":"publisher","first-page":"e2534","DOI":"10.1212\/WNL.0000000000011919","volume":"96","author":"M Geerts","year":"2021","unstructured":"Geerts, M. et al. Intravenous Immunoglobulin therapy in patients with painful idiopathic small fiber neuropathy. Neurology 96, e2534\u2013e2545. https:\/\/doi.org\/10.1212\/WNL.0000000000011919 (2021).","journal-title":"Neurology"},{"key":"33059_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/mus.27745","volume":"67","author":"CH Gibbons","year":"2023","unstructured":"Gibbons, C. H. et al. A double-blind placebo-controlled pilot study of Immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies. Muscle Nerve. 67, 363\u2013370. https:\/\/doi.org\/10.1002\/mus.27745 (2023).","journal-title":"Muscle Nerve"},{"key":"33059_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10286-024-01020-9","volume":"34","author":"S Vernino","year":"2024","unstructured":"Vernino, S. et al. Randomized controlled trial of intravenous Immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND). Clin. Auton. Res. Off J. Clin. Auton. Res. Soc. 34, 153\u2013163. https:\/\/doi.org\/10.1007\/s10286-024-01020-9 (2024).","journal-title":"Clin. Auton. Res. Off J. Clin. Auton. Res. Soc."},{"key":"33059_CR15","doi-asserted-by":"publisher","first-page":"102828","DOI":"10.1016\/j.autneu.2021.102828","volume":"235","author":"S Vernino","year":"2021","unstructured":"Vernino, S. et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National institutes of health expert consensus Meeting - Part 1. Auton. Neurosci. Basic. Clin. 235, 102828. https:\/\/doi.org\/10.1016\/j.autneu.2021.102828 (2021).","journal-title":"Auton. Neurosci. Basic. Clin."},{"key":"33059_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ana.26286","volume":"91","author":"P Novak","year":"2022","unstructured":"Novak, P. et al. Multisystem involvement in Post-Acute sequelae of coronavirus disease 19. Ann. Neurol. 91, 367\u2013379. https:\/\/doi.org\/10.1002\/ana.26286 (2022).","journal-title":"Ann. Neurol."},{"key":"33059_CR17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1212\/WNL.56.7.861","volume":"56","author":"V Novak","year":"2001","unstructured":"Novak, V. et al. Autonomic impairment in painful neuropathy. Neurology 56, 861\u2013868 (2001).","journal-title":"Neurology"},{"key":"33059_CR18","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1212\/WNL.0000000000010988","volume":"95","author":"R Freeman","year":"2020","unstructured":"Freeman, R. et al. Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria. Neurology 95, 1005\u20131014. https:\/\/doi.org\/10.1212\/WNL.0000000000010988 (2020).","journal-title":"Neurology"},{"key":"33059_CR19","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1093\/brain\/awn093","volume":"131","author":"G Devigili","year":"2008","unstructured":"Devigili, G. et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 131, 1912\u20131925. https:\/\/doi.org\/10.1093\/brain\/awn093 (2008).","journal-title":"Brain"},{"key":"33059_CR20","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1212\/WNL.0b013e3182120147","volume":"76","author":"L Zilliox","year":"2011","unstructured":"Zilliox, L. et al. Assessing autonomic dysfunction in early diabetic neuropathy: the survey of autonomic symptoms. Neurology 76, 1099\u20131105. https:\/\/doi.org\/10.1212\/WNL.0b013e3182120147 (2011).","journal-title":"Neurology"},{"key":"33059_CR21","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","volume":"87","author":"DM Sletten","year":"2012","unstructured":"Sletten, D. M. et al. COMPASS 31: A refined and abbreviated composite autonomic symptom score. Mayo Clin. Proc. 87, 1196\u20131201. https:\/\/doi.org\/10.1016\/j.mayocp.2012.10.013 (2012).","journal-title":"Mayo Clin. Proc."},{"key":"33059_CR22","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1038\/s41598-024-52368-x","volume":"14","author":"P Novak","year":"2024","unstructured":"Novak, P. et al. Mismatch between subjective and objective Dysautonomia. Sci. Rep. 14, 2513. https:\/\/doi.org\/10.1038\/s41598-024-52368-x (2024).","journal-title":"Sci. Rep."},{"key":"33059_CR23","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.clinthera.2005.08.002","volume":"27","author":"EJ Bastyr","year":"2005","unstructured":"Bastyr, E. J., Price, K. L., Bril, V. & MBBQ Study Group. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin. Ther. 27, 1278\u20131294. https:\/\/doi.org\/10.1016\/j.clinthera.2005.08.002 (2005).","journal-title":"Clin. Ther."},{"key":"33059_CR24","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1212\/WNL.0b013e3182872e80","volume":"80","author":"KF Cook","year":"2013","unstructured":"Cook, K. F. et al. Pain assessment using the NIH toolbox. Neurology 80, S49\u2013S53. https:\/\/doi.org\/10.1212\/WNL.0b013e3182872e80 (2013).","journal-title":"Neurology"},{"key":"33059_CR25","doi-asserted-by":"crossref","unstructured":"Novak, P. Autonomic Testing (Oxford University Press, 2019).","DOI":"10.1093\/med\/9780190889227.001.0001"},{"key":"33059_CR26","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1212\/WNL.0b013e31821e5563","volume":"76","author":"P Novak","year":"2011","unstructured":"Novak, P. Assessment of sympathetic index from the Valsalva maneuver. Neurology 76, 2010\u20132016. https:\/\/doi.org\/10.1212\/WNL.0b013e31821e5563 (2011).","journal-title":"Neurology"},{"key":"33059_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-017-0467-x","author":"P Novak","year":"2017","unstructured":"Novak, P. Electrochemical skin conductance: a systematic review. Clin. Auton. Res. Off J. Clin. Auton. Res. Soc. https:\/\/doi.org\/10.1007\/s10286-017-0467-x (2017).","journal-title":"Clin. Auton. Res. Off J. Clin. Auton. Res. Soc."},{"key":"33059_CR28","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1212\/WNL.0b013e3181a2e8b8","volume":"72","author":"CH Gibbons","year":"2009","unstructured":"Gibbons, C. H., Illigens, B. M. W., Wang, N. & Freeman, R. Quantification of sweat gland innervation: a clinical-pathologic correlation. Neurology 72, 1479\u20131486. https:\/\/doi.org\/10.1212\/WNL.0b013e3181a2e8b8 (2009).","journal-title":"Neurology"},{"key":"33059_CR29","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1007\/s10072-022-06007-w","volume":"43","author":"P Novak","year":"2022","unstructured":"Novak, P. Qpack-a python package for QASAT-quantitative scale for grading cerebral blood flow, autonomic testing, and skin biopsies. Neurol. Sci. Off J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol. 43, 4821\u20134828. https:\/\/doi.org\/10.1007\/s10072-022-06007-w (2022).","journal-title":"Neurol. Sci. Off J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"33059_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s13311-015-0391-5","volume":"13","author":"JD L\u00fcnemann","year":"2016","unstructured":"L\u00fcnemann, J. D., Quast, I. & Dalakas, M. C. Efficacy of intravenous Immunoglobulin in neurological diseases. Neurother. J. Am. Soc. Exp. Neurother. 13, 34\u201346. https:\/\/doi.org\/10.1007\/s13311-015-0391-5 (2016).","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"33059_CR31","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/14737175.2022.2169134","volume":"22","author":"MC Dalakas","year":"2022","unstructured":"Dalakas, M. C., Latov, N. & Kuitwaard, K. Intravenous Immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations. Expert Rev. Neurother. 22, 953\u2013962. https:\/\/doi.org\/10.1080\/14737175.2022.2169134 (2022).","journal-title":"Expert Rev. Neurother."},{"key":"33059_CR32","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1007\/s13311-021-01108-4","volume":"18","author":"MC Dalakas","year":"2021","unstructured":"Dalakas, M. C. Update on intravenous Immunoglobulin in neurology: modulating Neuro-autoimmunity, evolving factors on efficacy and dosing and challenges on stopping chronic IVIg therapy. Neurother. J. Am. Soc. Exp. Neurother. 18, 2397\u20132418. https:\/\/doi.org\/10.1007\/s13311-021-01108-4 (2021).","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"33059_CR33","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1468-1331.2008.02246.x","volume":"15","author":"I Elovaara","year":"2008","unstructured":"Elovaara, I. et al. EFNS guidelines for the use of intravenous Immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous Immunoglobulin in treatment of neurological diseases. Eur. J. Neurol. 15, 893\u2013908. https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02246.x (2008).","journal-title":"Eur. J. Neurol."},{"key":"33059_CR34","unstructured":"Rosner, B. Fundamentals of Biostatistics, 7th ed (Brooks\/Cole, 2011)."},{"key":"33059_CR35","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/sim.4780111406","volume":"11","author":"SL Zeger","year":"1992","unstructured":"Zeger, S. L. & Liang, K. Y. An overview of methods for the analysis of longitudinal data. Stat. Med. 11, 1825\u20131839. https:\/\/doi.org\/10.1002\/sim.4780111406 (1992).","journal-title":"Stat. Med."},{"key":"33059_CR36","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/ncp.10564","volume":"35","author":"R Ganesh","year":"2020","unstructured":"Ganesh, R., Bonnes, S. L. R. & DiBaise, J. K. Postural tachycardia syndrome: nutrition implications. Nutr. Clin. Pract. Off Publ Am. Soc. Parenter. Enter. Nutr. 35, 818\u2013825. https:\/\/doi.org\/10.1002\/ncp.10564 (2020).","journal-title":"Nutr. Clin. Pract. Off Publ Am. Soc. Parenter. Enter. Nutr."},{"key":"33059_CR37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/EJA.0000000000000436","volume":"33","author":"RG Hahn","year":"2016","unstructured":"Hahn, R. G. & Lyons, G. The half-life of infusion fluids: an educational review. Eur. J. Anaesthesiol. 33, 475\u2013482. https:\/\/doi.org\/10.1097\/EJA.0000000000000436 (2016).","journal-title":"Eur. J. Anaesthesiol."},{"key":"33059_CR38","doi-asserted-by":"publisher","first-page":"eado2106","DOI":"10.1126\/scitranslmed.ado2106","volume":"16","author":"AAR Antar","year":"2024","unstructured":"Antar, A. A. R. & Cox, A. L. Translating insights into therapies for long Covid. Sci. Transl. Med. 16, eado2106. https:\/\/doi.org\/10.1126\/scitranslmed.ado2106 (2024).","journal-title":"Sci. Transl. Med."},{"key":"33059_CR39","doi-asserted-by":"publisher","first-page":"eadr1032","DOI":"10.1126\/scitranslmed.adr1032","volume":"16","author":"RE Hamlin","year":"2024","unstructured":"Hamlin, R. E. et al. Sex differences and immune correlates of long Covid development, symptom persistence, and resolution. Sci. Transl. Med. 16, eadr1032. https:\/\/doi.org\/10.1126\/scitranslmed.adr1032 (2024).","journal-title":"Sci. Transl. Med."},{"key":"33059_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/mus.24526","volume":"51","author":"M Berger","year":"2015","unstructured":"Berger, M. & Allen, J. A. Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach. Muscle Nerve. 51, 315\u2013326. https:\/\/doi.org\/10.1002\/mus.24526 (2015).","journal-title":"Muscle Nerve"},{"key":"33059_CR41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature10134","volume":"475","author":"RM Anthony","year":"2011","unstructured":"Anthony, R. M., Kobayashi, T., Wermeling, F. & Ravetch, J. V. Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature 475, 110\u2013113. https:\/\/doi.org\/10.1038\/nature10134 (2011).","journal-title":"Nature"},{"key":"33059_CR42","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","volume":"139","author":"EE Perez","year":"2017","unstructured":"Perez, E. E. et al. Update on the use of Immunoglobulin in human disease: a review of evidence. J. Allergy Clin. Immunol. 139, S1\u2013S46. https:\/\/doi.org\/10.1016\/j.jaci.2016.09.023 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"33059_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11910-019-1020-1","volume":"19","author":"K Farhad","year":"2019","unstructured":"Farhad, K. Current diagnosis and treatment of painful small fiber neuropathy. Curr. Neurol. Neurosci. Rep. 19, 103. https:\/\/doi.org\/10.1007\/s11910-019-1020-1 (2019).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"33059_CR44","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1098\/rstb.2010.0403","volume":"366","author":"K Meissner","year":"2011","unstructured":"Meissner, K. The placebo effect and the autonomic nervous system: evidence for an intimate relationship. Philos. Trans. R Soc. B Biol. Sci. 366, 1808\u20131817. https:\/\/doi.org\/10.1098\/rstb.2010.0403 (2011).","journal-title":"Philos. Trans. R Soc. B Biol. Sci."},{"key":"33059_CR45","doi-asserted-by":"publisher","first-page":"eado2103","DOI":"10.1126\/scitranslmed.ado2103","volume":"16","author":"A Marques","year":"2024","unstructured":"Marques, A. Symptoms after Lyme disease: what\u2019s past is prologue. Sci. Transl. Med. 16, eado2103. https:\/\/doi.org\/10.1126\/scitranslmed.ado2103 (2024).","journal-title":"Sci. Transl. Med."},{"key":"33059_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ana.26268","volume":"91","author":"ACY Chan","year":"2022","unstructured":"Chan, A. C. Y. et al. Novel autoantibodies in idiopathic small fiber neuropathy. Ann. Neurol. 91, 66\u201377. https:\/\/doi.org\/10.1002\/ana.26268 (2022).","journal-title":"Ann. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33059-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33059-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33059-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T13:40:25Z","timestamp":1769175625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33059-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33059"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33059-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PN is a current or previous shareholder of Moderna, Editas Medicine, Novavax, and Pfizer. PN received royalties from Oxford University Press and he is advisor - independent Contractor for Dysimmune Diseases Foundation. The remaining authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3151"}}